​

Inovio Pharmaceuticals Ownership | Who Owns Inovio Pharmaceuticals?


OverviewForecastFinancialsChartTranscripts

Inovio Pharmaceuticals Ownership Summary


Inovio Pharmaceuticals is owned by 4.94% institutional investors, 0.33% insiders, and 94.73% retail investors. Fmr is the largest institutional shareholder, holding 20.61% of INO shares. Fidelity Small Cap Growth is the top mutual fund, with 9.83% of its assets in Inovio Pharmaceuticals shares.

INO Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockInovio Pharmaceuticals4.94%0.33%94.73%
SectorHealthcare Stocks 247.07%12.15%-159.22%
IndustryBiotech Stocks 385.89%11.79%-297.68%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr16.82M20.61%$20.52M
Vanguard group3.32M6.36%$5.77M
Vanguard capital management4.60M5.64%$5.61M
Marshall wace, llp2.28M2.79%$2.78M
Renaissance1.51M1.85%$1.85M
Geode capital management1.00M1.23%$1.22M
Quadrature capital875.12K1.07%$1.07M
Blackrock funding, inc. /de763.81K0.94%$931.85K
Jane street group732.94K0.90%$894.19K
Vanguard fiduciary trust622.86K0.76%$759.89K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Boxer capital management2.84M0.24%$3.13M
Adar1 capital management2.14M0.11%$2.36M
Eversept partners, lp1.04M0.06%$1.14M
Green alpha advisors68.06K0.05%$74.86K
Gsa capital partners llp265.01K0.02%$292.00K
Gmt capital126.12K0.01%$153.87K
Quadrature capital875.12K0.01%$1.07M
Covestor5.12K0.00%$6.00K
Bridgeway capital management173.00K0.00%$190.30K
Janus henderson group3.31M0.00%$5.77M

Top Buyers

HolderShares% AssetsChange
Fmr16.82M0.00%8.36M
Marshall wace, llp2.28M0.00%2.28M
Renaissance1.51M0.00%1.15M
Vanguard capital management4.60M0.00%948.79K
Two sigma investments, lp1.24M0.00%849.39K

Top Sellers

HolderShares% AssetsChange
Deep track capital, lp---1.98M
Stonepine capital management---1.35M
D. e. shaw1.35M0.00%-861.16K
Adage capital partners gp---804.96K
Aigh capital management---654.12K

New Positions

HolderShares% AssetsChangeValue
Caption management478.95K0.00%478.95K$526.85K
Nomura150.00K0.00%150.00K$165.00K
Dz bank ag deutsche zentral genossenschafts bank, frankfurt am main133.65K0.00%133.65K$147.01K
Two sigma advisers, lp108.70K0.00%108.70K$254.36K
Mount yale investment advisors38.76K0.00%38.76K$47.29K

Sold Out

HolderChange
Ameritas advisory services-2.00
Hm payson-2.00
Sachetta-3.00
Johnson financial group-4.00
S&t bank/pa-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20261124.67%34,155,3368.90%423.99%5537.50%16-20.00%
Mar 31, 202655-48.11%4,340,403-86.86%-0.02%16-62.79%9-62.50%
Dec 31, 202567-35.58%6,818,031-67.10%130.46%21-58.82%15-31.82%
Sep 30, 202599-1.00%20,701,614120.05%539.08%498.89%20-25.93%
Jun 30, 2025106-1.85%10,167,785-25.24%262.11%47-9.62%293.57%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Small Cap Growth10.83M9.83%3.84M
Fidelity Small Cap Growth K65.54M5.03%2.01M
Vanguard MStar Total Stk Mkt Idx Invest3.28M3.18%-
Vanguard Morn Total Stk Mkt Idx Investor2.60M3.16%-
Vanguard Total Stock Mkt Idx Inv2.60M3.16%-
Strategic Advisers Fidelity US TtlStk2.69M2.44%2.69M
Vanguard US Total Market Shares ETF818.82K2.23%-
Vanguard Institutional Extnd Mkt Idx Tr963.33K1.17%-
Fidelity Advisor Biotechnology I883.08K1.08%-
Strategic Advisers U.S. Total Stock983.95K0.89%983.95K

Recent Insider Transactions


DateNameRoleActivityValue
Jun 05, 2023Zoth Lota S.-Sell$3.19K
Mar 13, 2023Weiner David B.-Sell$6.71K
Feb 27, 2023Weiner David B.-Sell$14.94K
Aug 11, 2022Weiner David B. Sell$31.59K
Jul 20, 2022BENITO SIMON X Sell$4.50K

Insider Transactions Trends


DateBuySell
2026 Q2--
2026 Q1--
2025 Q2--
2025 Q1--
2024 Q4--

INO Ownership FAQ


Who Owns Inovio Pharmaceuticals?

Inovio Pharmaceuticals shareholders are primarily institutional investors at 4.94%, followed by 0.33% insiders and 94.73% retail investors. The average institutional ownership in Inovio Pharmaceuticals's industry, Biotech Stocks , is 385.89%, which Inovio Pharmaceuticals falls below.

Who owns the most shares of Inovio Pharmaceuticals?

Inovio Pharmaceuticals’s largest shareholders are Fmr (16.82M shares, 20.61%), Vanguard group (3.32M shares, 6.36%), and Vanguard capital management (4.6M shares, 5.64%). Together, they hold 32.60% of Inovio Pharmaceuticals’s total shares outstanding.

Does Blackrock own Inovio Pharmaceuticals?

BlackRock is not among the top 10 institutional shareholders of Inovio Pharmaceuticals.

Who is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Boxer capital management is Inovio Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.24% of its assets in 2.84M Inovio Pharmaceuticals shares, valued at 3.13M$.

Who is the top mutual fund holder of Inovio Pharmaceuticals shares?

Fidelity Small Cap Growth is the top mutual fund holder of Inovio Pharmaceuticals shares, with 9.83% of its total shares outstanding invested in 10.83M Inovio Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools